ES8604209A1 - Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos - Google Patents

Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos

Info

Publication number
ES8604209A1
ES8604209A1 ES85544234A ES544234A ES8604209A1 ES 8604209 A1 ES8604209 A1 ES 8604209A1 ES 85544234 A ES85544234 A ES 85544234A ES 544234 A ES544234 A ES 544234A ES 8604209 A1 ES8604209 A1 ES 8604209A1
Authority
ES
Spain
Prior art keywords
compounds
formula
substituted
producing
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES85544234A
Other languages
English (en)
Other versions
ES544234A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58048989A external-priority patent/JPS59225182A/ja
Priority claimed from JP58221470A external-priority patent/JPS60115578A/ja
Priority claimed from JP58221469A external-priority patent/JPS60115577A/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of ES544234A0 publication Critical patent/ES544234A0/es
Publication of ES8604209A1 publication Critical patent/ES8604209A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS DE 2-AZETIDINONA 4-SUSTITUIDOS Y DE SUS SALES, DE FORMULA (I), EN LA QUE R1, R3 Y R4 REPRESENTAN HIDROGENO O ALQUILO INFERIOR; X, Y Y R2 PUEDEN SER VARIOS TIPOS DE RADICALES; Y N VALE 0-3. COMPRENDE LA REACCION DE UN ACIDO CARBOXILICO, DE FORMULA (II), O UN DERIVADO REACTIVO DEL MISMO, CON UNA AMINA CICLICA, DE FORMULA (III), EN LAS QUE TODOS LOS SIMBOLOS TIENEN LOS MISMOS SIGNIFICADOS QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN DISOLUCION EN DIMETILFORMAMIDA, A UNA TEMPERATURA COMPRENDIDA ENTRE 0JC Y LA AMBIENTE, Y DESPUES DE SEPARAR EL DISOLVENTE, EL PRODUCTO OBTENIDO SE SEPARA Y PURIFICA POR CRISTALIZACION EN METANOL. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE LAS PERTURBACIONES DE LA CONCIENCIA EN LA ESQUIZOFRENIA, HERIDAS EN LA CABEZA, O PARA MEJORAR LA HIPOBULIA Y PERDIDA DE MEMORIA.
ES85544234A 1983-03-25 1985-06-14 Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos Expired ES8604209A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP58048989A JPS59225182A (ja) 1983-03-25 1983-03-25 ２−アゼチジノン−４−カルボン酸の誘導体
JP58221470A JPS60115578A (ja) 1983-11-25 1983-11-25 ２−アゼチジノン−４−置換化合物
JP58221469A JPS60115577A (ja) 1983-11-25 1983-11-25 ２−アゼチジノン−４−置換体

Publications (2)

Publication Number Publication Date
ES544234A0 ES544234A0 (es) 1986-01-16
ES8604209A1 true ES8604209A1 (es) 1986-01-16

Family

ID=27293483

Family Applications (4)

Application Number Title Priority Date Filing Date
ES530960A Expired ES8600279A1 (es) 1983-03-25 1984-03-23 Un procedimiento para la produccion de compuestos de 2-azetidinona 4-sustituidos
ES544236A Expired ES8604136A1 (es) 1983-03-25 1985-06-14 Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos
ES544235A Expired ES8604208A1 (es) 1983-03-25 1985-06-14 Un procedimiento para la produccion de compuestos de 2-azetidinona 4-sustituidos.
ES85544234A Expired ES8604209A1 (es) 1983-03-25 1985-06-14 Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES530960A Expired ES8600279A1 (es) 1983-03-25 1984-03-23 Un procedimiento para la produccion de compuestos de 2-azetidinona 4-sustituidos
ES544236A Expired ES8604136A1 (es) 1983-03-25 1985-06-14 Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos
ES544235A Expired ES8604208A1 (es) 1983-03-25 1985-06-14 Un procedimiento para la produccion de compuestos de 2-azetidinona 4-sustituidos.

Country Status (8)

Country Link
US (3) US4564609A (es)
EP (1) EP0123444B1 (es)
KR (3) KR870000357B1 (es)
CA (1) CA1256650A (es)
DE (1) DE3476399D1 (es)
DK (1) DK164684A (es)
ES (4) ES8600279A1 (es)
NO (1) NO158740C (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719207A (en) * 1984-06-25 1988-01-12 Yamanouchi Pharmaceutical Co., Ltd. CNS active substituted azetidinone compounds
JPS6253994A (ja) 1985-05-09 1987-03-09 Yamanouchi Pharmaceut Co Ltd １−置換シリル−４−オキソ−２−アゼチジンカルボン酸低級アルキルエステル
ZA868957B (en) * 1985-12-06 1987-07-29 Yamanouchi Pharma Co Ltd Crystals of nalpha-(((s)-4-oxo-2-azetidinyl)carbonyl)-l-histidyl-l-prolinamide and process for producing the crystals
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
US5151497A (en) * 1989-02-21 1992-09-29 Japan Tobacco Inc. Histidyl peptide derivatives
DK437289D0 (da) * 1989-09-04 1989-09-04 Hans Bundgaard Prodrug derivatives of thyrotropin-releasing hormone (trh)
IT1249728B (it) * 1991-11-06 1995-03-09 Sigma Tau Ind Farmaceuti Derivati delle prolinammide quali attivatori della memoria e dei processi di apprendimento e composizioni farmaceutiche che li contengono
WO1998050032A1 (en) * 1997-05-09 1998-11-12 Smithkline Beecham Corporation BETA-LACTAM INHIBITORS OF CoA-IT
US20020151502A1 (en) * 1997-10-09 2002-10-17 Albert Sattin Tri-peptides for neurological and neurobehavior applications
US7202279B1 (en) * 1998-02-11 2007-04-10 Georgetown University Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
AU2001266347A1 (en) * 2000-07-11 2002-01-21 Shionogi And Co., Ltd. Enteric preparations containing physiologically active peptides
TWI285110B (en) 2000-08-31 2007-08-11 Shionogi & Co Parkinson disease therapeutic agent
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
IL156445A0 (en) * 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
TW200840563A (en) * 2001-01-26 2008-10-16 Schering Corp Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(S) and treatments for vascular indications
EP1385548B1 (en) * 2001-01-26 2007-05-23 Schering Corporation Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
PT1363668E (pt) * 2001-01-26 2007-11-07 Schering Corp Combinaçoes de sequestrante(s) de ácidos biliares e inibidor(es) de absorção de esterol e tratamento de indicações vasculares
NZ542090A (en) * 2001-01-26 2006-09-29 Schering Corp Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
KR20070120617A (ko) * 2001-01-26 2007-12-24 쉐링 코포레이션 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
WO2002096415A2 (en) * 2001-05-25 2002-12-05 Schering Corporation Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
DE60229406D1 (de) * 2001-09-21 2008-11-27 Schering Corp Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
EP1429756B1 (en) * 2001-09-21 2006-11-22 Schering Corporation Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
CA2504916A1 (en) * 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
DE602004018617D1 (de) * 2003-03-07 2009-02-05 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2004081002A1 (en) * 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
WO2004081004A1 (en) * 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
WO2005046797A2 (en) * 2003-11-05 2005-05-26 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
KR101137503B1 (ko) * 2009-07-14 2012-04-20 웰이앤씨 주식회사 고분자 고체 지지체를 이용한 히스티딜-프롤린아미드 유도체의 제조 방법
US9446992B2 (en) 2013-08-16 2016-09-20 Los Alamos National Security, Llc Compounds and methods for improving plant performance

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
GB1523598A (en) * 1975-03-08 1978-09-06 Reckitt & Colmann Prod Ltd Tripeptides
US4271164A (en) * 1979-04-16 1981-06-02 Warner-Lambert Company 6-Substituted-arylpyrido[2,3-d]pyrimidin-7-amines and derivatives
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4426378A (en) * 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant

Also Published As

Publication number Publication date
EP0123444A1 (en) 1984-10-31
KR880009549A (ko) 1988-09-15
ES544236A0 (es) 1986-01-16
CA1256650A (en) 1989-06-27
KR880009550A (ko) 1988-09-15
US4564609A (en) 1986-01-14
ES530960A0 (es) 1985-10-01
DK164684D0 (da) 1984-03-23
ES544234A0 (es) 1986-01-16
KR890002104B1 (ko) 1989-06-19
US4636567A (en) 1987-01-13
NO158740B (no) 1988-07-18
DE3476399D1 (en) 1989-03-02
NO841158L (no) 1984-09-26
US4610821A (en) 1986-09-09
EP0123444B1 (en) 1989-01-25
ES8604208A1 (es) 1986-01-16
ES8600279A1 (es) 1985-10-01
KR890002105B1 (ko) 1989-06-19
NO158740C (no) 1988-10-26
ES544235A0 (es) 1986-01-16
DK164684A (da) 1984-09-26
KR840008021A (ko) 1984-12-12
KR870000357B1 (ko) 1987-03-05
ES8604136A1 (es) 1986-01-16

Similar Documents

Publication Publication Date Title
ES8604208A1 (es) Un procedimiento para la produccion de compuestos de 2-azetidinona 4-sustituidos.
EP0218999A3 (en) New quinazoline derivatives, process for their production and pharmaceutical compositions comprising them
DE3280172D1 (de) 2-oxyimino-3-oxo-buttersaeurederivate und deren herstellungsverfahren.
ATE206401T1 (de) Zwischenprodukte für die herstellung von derivaten der 4-oxochinolin-3-carbonsäure
HUT45984A (en) Process for production of quinoline-derivatives and of their medically acceptable acid-additioned salts
JPS5620571A (en) Manufacture of thienamycin and intermediate thereof
HUT47241A (en) Process for producing alkyl-sulfonanilide derivatives and pharmaceuticals comprising them
HUT46895A (en) Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect
PH17378A (en) N-naphthoylglycine derivatives and method of use thereof
GR3015149T3 (en) Urea derivatives, their production, and pharmaceutical compositions containing them.
HU910748D0 (en) New substituted amine compounds and process for producing them
DE3564263D1 (en) Process for preparing azetidine derivatives and intermediates therein
GR3003126T3 (en) Quinolinecarboxylic acid derivatives, a composition comprising the same, process for preparing the same, and the use of the same for the manufacture of medicaments
ES2171389T3 (es) Derivados anticonvulsivos de aminoacidos.
DE3368612D1 (en) Process for the production of guanidinoheterocyclic derivatives
DE3262353D1 (en) N,n-disubstituted alkenamides and phenylalkenamides, processes for their production and their use as pharmaceuticals
AU561092B2 (en) N-(2,6 disubstituted aromatic)-n:-pyridinyl ureas
TW265342B (es)
HUT59371A (en) Process for producing aliphatic amides and their salts
PT74966A (en) N-<2-(2-amino-2-phenylethyl)phenyl>-2,2-dimethyl-propanamid and derivatives and a process for preparing the same
YU43584B (en) Process for obtaining ethylenediaminic, mono-i diethanolaminic salts of n-(6-methyl-2-pyridyl)-2-methyl-4-hydroxy-2h-1,2benzothiazine-3-carboxamide-1,1-d

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303